hers compounded semaglutide Hims & offers Wegovy for $99 a month to select professions The FDA announced plans to

A provider may recommend semaglutide if: You prefer a medication with a longer track record You have specific cardiovascular considerations You respond well to GLP-1 therapy A provider may recommend tirzepatide if: Maximizing weight loss is a primary goal You have insulin resistance You qualify medically and can tolerate the medication Because every patient responds differently, a personalized consultation is essential

Hypoglycemia Though tirzepatide works in glucose-dependent ways that reduce hypoglycemia risk, low blood sugar can occur, particularly if youre taking other diabetes medications or insulin

[DOI] [PMC free article] [PubMed] [Google Scholar] 53.Shi X, Jiang A, Qiu Z, Lin A, Liu Z, Zhu L, et al

Your clinician should explain both the benefits of GLP-1 therapyincluding improved glycaemic control, weight loss, and cardiovascular protectionand the theoretical risks based on animal data

Glucagon-like peptide-1 agonists and risk of acute pancreatitis in patients with type 2 diabetes